{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:53:58Z","timestamp":1785894838157,"version":"3.56.0"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100017605","name":"Shaanxi University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017605","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.bioorg.2020.104557","type":"journal-article","created":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T02:52:37Z","timestamp":1608087157000},"page":"104557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"special_numbering":"C","title":["Research progress in biological activities of succinimide derivatives"],"prefix":"10.1016","volume":"108","author":[{"given":"Zefeng","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangxin","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaotong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Nian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifa","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.bioorg.2020.104557_b0005","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/j.1528-1167.2011.03024.x","article-title":"Modern antiepileptic drug development has failed to deliver: Ways out of the current dilemma","volume":"52","author":"Loescher","year":"2011","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.bioorg.2020.104557_b0010","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1176\/appi.ajp.158.10.1722","article-title":"Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment","volume":"158","author":"Sumiyoshi","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"12","key":"10.1016\/j.bioorg.2020.104557_b0015","doi-asserted-by":"crossref","first-page":"6246","DOI":"10.1128\/AAC.00977-13","article-title":"Efficacy of Tecovirimat (ST-246) in Nonhuman Primates Infected with Variola Virus (Smallpox)","volume":"57","author":"Mucker","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.bioorg.2020.104557_b0020","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s40265-018-0967-6","article-title":"Tecovirimat: First Global Approval","volume":"78","author":"Hoy","year":"2018","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104557_b0025","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa1705688","article-title":"Oral Tecovirimat for the Treatment of Smallpox","volume":"379","author":"Grosenbach","year":"2018","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104557_b0030","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1124\/jpet.110.167346","article-title":"Pharmacological profile of lurasidone, a novel antipsychotic agent with potent 5-hydroxytryptamine 7 (5-HT7) and 5-HT1A receptor activity","volume":"334","author":"Ishibashi","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104557_b0035","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2165\/00023210-200115040-00006","article-title":"Perospirone","volume":"15","author":"Onrust","year":"2001","journal-title":"CNS Drugs"},{"issue":"15","key":"10.1016\/j.bioorg.2020.104557_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115577","article-title":"Synthesis and evaluation of F-18 labeled crizotinib derivative F-18 FPC as a novel PET probe for imaging c-MET-positive NSCLC tumor","volume":"28","author":"Lin","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0045","first-page":"1","article-title":"A randomized, double-blind, placebo-controlled, phase 3 study of tivantinib in Japanese patients with MET-high hepatocellular carcinoma","volume":"00","author":"Kudo","year":"2020","journal-title":"Cancer Sci."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104557_b0050","doi-asserted-by":"crossref","first-page":"678","DOI":"10.2174\/138955710791572442","article-title":"Recent advances in the chemistry of phthalimide analogues and their therapeutic potential","volume":"10","author":"Sharma","year":"2010","journal-title":"Mini-Rev. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2020.104557_b0055","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1021\/acs.chemrev.7b00763","article-title":"Tetramethylpiperidine N-Oxyl (TEMPO), phthalimide N-Oxyl (PINO), and related N-Oxyl species: electrochemical properties and their use in electrocatalytic reactions","volume":"118","author":"Nutting","year":"2018","journal-title":"Chem. Rev."},{"issue":"2","key":"10.1016\/j.bioorg.2020.104557_b0060","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/asia.201200684","article-title":"Asymmetric organocatalytic addition reactions of maleimides: a promising approach towards the synthesis of chiral succinimide derivatives","volume":"8","author":"Chauhan","year":"2013","journal-title":"Chem.-Asian J."},{"issue":"16","key":"10.1016\/j.bioorg.2020.104557_b0065","doi-asserted-by":"crossref","first-page":"7017","DOI":"10.1021\/jf801171x","article-title":"Anti-inflammatory activities of new succinic and maleic derivatives from the fruiting body of Antrodia camphorata","volume":"56","author":"Chien","year":"2008","journal-title":"J. Agric. Food Chem."},{"issue":"10","key":"10.1016\/j.bioorg.2020.104557_b0070","doi-asserted-by":"crossref","first-page":"840","DOI":"10.7164\/antibiotics.50.840","article-title":"Novel anthelmintic metabolites from an Aspergillus species; the aspergillimides","volume":"50","author":"Banks","year":"1997","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"13","key":"10.1016\/j.bioorg.2020.104557_b0075","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1021\/ol060926x","article-title":"Hirsutellone F, a dimer of antitubercular alkaloids from the seed fungus Trichoderma species BCC 7579","volume":"8","author":"Isaka","year":"2006","journal-title":"Org. Lett."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104557_b0080","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1021\/np0499620","article-title":"Cytotoxic lissoclimide-type diterpenes from the molluscs Pleurobranchus albiguttatus and Pleurobranchus forskalii","volume":"67","author":"Fu","year":"2004","journal-title":"J. Nat. Prod."},{"issue":"20","key":"10.1016\/j.bioorg.2020.104557_b0085","doi-asserted-by":"crossref","first-page":"6954","DOI":"10.1016\/j.bmc.2006.06.043","article-title":"Cytotoxic labdane alkaloids from an ascidian Lissoclinum sp.: Isolation, structure elucidation, and structure-activity relationship","volume":"14","author":"Uddin","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.bioorg.2020.104557_b0090","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1038\/nchem.2800","article-title":"Synthesis facilitates an understanding of the structural basis for translation inhibition by the lissoclimides","volume":"9","author":"Konst","year":"2017","journal-title":"Nat. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104557_b0095","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1021\/jo00087a020","article-title":"Andrimid and Moiramides A-C, metabolites produced in culture by a marine isolate of the bacterium Pseudomonas-fluorescens-structure elucidation and biosynthesis","volume":"59","author":"Needham","year":"1994","journal-title":"J. Org. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104557_b0100","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.bmcl.2004.12.002","article-title":"Pyrrolidinedione derivatives as antibacterial agents with a novel mode of action","volume":"15","author":"Pohlmann","year":"2005","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"21","key":"10.1016\/j.bioorg.2020.104557_b0105","doi-asserted-by":"crossref","first-page":"8947","DOI":"10.1021\/jm501082n","article-title":"Design, Synthesis, and Antibacterial Properties of Dual-Ligand Inhibitors of Acetyl-CoA Carboxylase","volume":"57","author":"Silvers","year":"2014","journal-title":"J. Med. Chem."},{"issue":"20","key":"10.1016\/j.bioorg.2020.104557_b0110","doi-asserted-by":"crossref","first-page":"5366","DOI":"10.1021\/ol4026809","article-title":"Nitrosporeusines A and B, Unprecedented Thioester-Bearing Alkaloids from the Arctic Streptomyces nitrosporeus","volume":"15","author":"Yang","year":"2013","journal-title":"Org. Lett."},{"issue":"10","key":"10.1016\/j.bioorg.2020.104557_b0115","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.tetlet.2015.01.143","article-title":"First synthesis of nitrosporeusines, alkaloids with multiple biological activities","volume":"56","author":"Philkhana","year":"2015","journal-title":"Tetrahedron Lett."},{"issue":"3","key":"10.1016\/j.bioorg.2020.104557_b0120","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.bbrc.2019.05.151","article-title":"Nitrosporeusine A attenuates sepsis-associated acute kidney injury through the downregulation of IL-6\/sIL-6R axis activation-mediated PGC-1 alpha suppression","volume":"515","author":"Zhao","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bioorg.2020.104557_b0125","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejmech.2017.04.015","article-title":"Identification of new anti-inflammatory agents based on nitrosporeusine natural products of marine origin","volume":"135","author":"Philkhana","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0130","article-title":"Excavating anticonvulsant compounds from prescriptions of Traditional Chinese Medicine in the treatment of epilepsy","volume":"1\u201331","author":"Zhao","year":"2018","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.bioorg.2020.104557_b0135","doi-asserted-by":"crossref","first-page":"102832","DOI":"10.1016\/j.bioorg.2019.03.006","article-title":"Excavating precursors from the traditional Chinese herb Polygala tenuifolia and Gastrodia elata: Synthesis, anticonvulsant activity evaluation of 3,4,5-trimethoxycinnamic acid (TMCA) ester derivatives","volume":"88","author":"Zhao","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/epi.12024","article-title":"How did phenobarbital's chemical structure affect the development of subsequent antiepileptic drugs (AEDs)?","volume":"53","author":"Bialer","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.bioorg.2020.104557_b0145","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.1021\/ja01120a044","article-title":"An investigation of 2-(substituted phenyl)succinimides","volume":"75","author":"Miller","year":"1953","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2020.104557_b0150","first-page":"283","article-title":"Clinical pharmacology of ethosuximide","author":"Sherwin","year":"1978","journal-title":"Raven"},{"issue":"2","key":"10.1016\/j.bioorg.2020.104557_b0155","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1734-1140(09)70024-6","article-title":"Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions","volume":"61","author":"Luszczki","year":"2009","journal-title":"Pharmacol. Rep."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104557_b0160","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1586\/14737175.3.1.107","article-title":"The evolution of antiepileptic drugs for mood stabilization and their main mechanisms of action","volume":"3","author":"Amann","year":"2003","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.bioorg.2020.104557_b0165","unstructured":"G.H. Glaser, J.K. Penry, D.M. Woodbury, Editors, Advances in Neurology, Vol. 27: Antiepileptic Drugs: Mechanisms of Action, Raven Press1980."},{"issue":"2","key":"10.1016\/j.bioorg.2020.104557_b0170","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/jps.2600620234","article-title":"Anticonvulsant properties of Mannich base derivatives of 2-phenylsuccinimide. 3","volume":"62","author":"Magarian","year":"1973","journal-title":"J. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.bioorg.2020.104557_b0175","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1021\/jm00219a020","article-title":"Potential long-acting anticonvulsants. 2. Synthesis and activity of succinimides containing an alkylating group on nitrogen or at the 3 position","volume":"20","author":"Kornet","year":"1977","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104557_b0180","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1002\/jps.2600800818","article-title":"Synthesis and anticonvulsant evaluation of some new 2-benzylsuccinimides","volume":"80","author":"Goehring","year":"1991","journal-title":"J. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.bioorg.2020.104557_b0185","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0014-827X(99)00033-6","article-title":"Synthesis, physicochemical and anticonvulsant properties of new N-pyridyl derivatives of 3-phenyl- and 3,3-diphenyl-succinimides","volume":"54","author":"Obniska","year":"1999","journal-title":"Farmaco"},{"issue":"9","key":"10.1016\/j.bioorg.2020.104557_b0190","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1016\/j.bmc.2008.03.037","article-title":"Design, synthesis, and anticonvulsant activity of N-phenylamino derivatives of 3,3-dialkyl-pyrrolidine-2,5-diones and hexahydro-isoindole-1,3-diones","volume":"16","author":"Kaminski","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"5","key":"10.1016\/j.bioorg.2020.104557_b0195","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/j.ejmech.2008.05.020","article-title":"Synthesis and anticonvulsant activity of new N- (4-arylpiperazin-1-yl)-alkyl derivatives of 3-phenyl-pyrrolidine-2,5-dione","volume":"44","author":"Obniska","year":"2009","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2020.104557_b0200","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/ardp.200900250","article-title":"Synthesis and Anticonvulsant Properties of New Mannich Bases Derived from 3-Aryl-pyrrolidine-2,5-diones. Part 1","volume":"343","author":"Obniska","year":"2010","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2020.104557_b0205","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejmech.2015.07.017","article-title":"Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2,5-dioxo-pyrrolidin-1-yl-acetic acid","volume":"102","author":"Obniska","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2020.104557_b0210","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.3109\/14756366.2015.1088842","article-title":"Synthesis and anticonvulsant activity of new N-mannich bases derived from benzhydryl- and isopropyl-pyrrolidine-2,5-dione","volume":"31","author":"Rybka","year":"2016","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172890","article-title":"Analgesic and antiallodynic activity of novel anticonvulsant agents derived from 3-benzhydryl-pyrrolidine-2,5-dione in mouse models of nociceptive and neuropathic pain","volume":"869","author":"Rapacz","year":"2020","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.bioorg.2020.104557_b0220","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1016\/j.bmc.2016.04.066","article-title":"Design, synthesis and anticonvulsant activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)propanamides and -butanamides","volume":"24","author":"Kaminski","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104557_b0225","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.bmc.2015.12.027","article-title":"New hybrid molecules with anticonvulsant and antinociceptive activity derived from 3-methyl- or 3,3-dimethyl-1- 1-oxo-1-(4-phenylpiperazin-1-yl)propan-2-yl pyrrolidine- 2,5-diones","volume":"24","author":"Kaminski","year":"2016","journal-title":"Bioorg. Med. Chem."},{"issue":"22","key":"10.1016\/j.bioorg.2020.104557_b0230","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/cmdc.201700539","article-title":"Synthesis and Determination of Lipophilicity, Anticonvulsant Activity, and Preliminary Safety of 3-Substituted and 3-Unsubstituted N- (4-Arylpiperazin-1-yl)alkyl pyrrolidine-2,5-dione Derivatives","volume":"12","author":"Rybka","year":"2017","journal-title":"Chemmedchem"},{"issue":"6","key":"10.1016\/j.bioorg.2020.104557_b0235","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/j.bmcl.2017.02.002","article-title":"Synthesis and evaluation of anticonvulsant properties of new N-Mannich bases derived from pyrrolidine-2,5-dione and its 3-methyl-, 3-isopropyl, and 3-benzhydryl analogs","volume":"27","author":"Rybka","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104557_b0240","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1021\/acschemneuro.8b00476","article-title":"KA-11, a Novel Pyrrolidine-2,5-dione Derived Broad-Spectrum Anticonvulsant: Its Antiepileptogenic, Antinociceptive Properties and in Vitro Characterization","volume":"10","author":"Socala","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.bioorg.2020.104557_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2019.107849","article-title":"Evaluation of the impact of compound C11 a new anticonvulsant candidate on cognitive functions and hippocampal neurogenesis in mouse brain","volume":"163","author":"Andres-Mach","year":"2020","journal-title":"Neuropharmacology"},{"issue":"20","key":"10.1016\/j.bioorg.2020.104557_b0250","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1002\/cmdc.201900367","article-title":"Chirality as an Important Factor for the Development of New Antiepileptic Drugs","volume":"14","author":"Abram","year":"2019","journal-title":"Chemmedchem"},{"issue":"20","key":"10.1016\/j.bioorg.2020.104557_b0255","doi-asserted-by":"crossref","first-page":"8565","DOI":"10.1021\/acs.jmedchem.7b01114","article-title":"Multifunctional hybrid compounds derived from 2-(2,5-dioxopyrrolidin-1-yl)-3-methoxypropanamides with anticonvulsant and antinociceptive properties","volume":"60","author":"Abram","year":"2017","journal-title":"J. Med. Chem."},{"issue":"13","key":"10.1016\/j.bioorg.2020.104557_b0260","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1021\/acschemneuro.0c00257","article-title":"Multitargeted Compounds Derived from (2,5-Dioxopyrrolidin-1-yl)(phenyl)-Acetamides as Candidates for Effective Anticonvulsant and Antinociceptive Agents","volume":"11","author":"Abram","year":"2020","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104557_b0265","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.bbrc.2019.10.204","article-title":"Sensation of TRPV1 via 5-hydroxytryptamine signaling modulates pain hypersensitivity in a 6-hydroxydopamine induced mice model of Parkinson's disease","volume":"521","author":"Li","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bioorg.2020.104557_b0270","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1177\/096368970000900509","article-title":"Initial characterization of the transplant of immortalized chromaffin cells for the attenuation of chronic neuropathic pain","volume":"9","author":"Eaton","year":"2000","journal-title":"Cell Transplant."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104557_b0275","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pain.2007.08.009","article-title":"Dual influence of the striatum on neuropathic hypersensitivity","volume":"137","author":"Pertovaara","year":"2008","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.bioorg.2020.104557_b0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2007.01.028","article-title":"The neuronal 5-HT3 receptor network after 20 years of research - Evolving concepts in management of pain and inflammation","volume":"560","author":"Faerber","year":"2007","journal-title":"Eur. J. Pharmacol."},{"issue":"13","key":"10.1016\/j.bioorg.2020.104557_b0285","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2174\/1381612821666141121114917","article-title":"Serotonergic System and Its Role in Epilepsy and Neuropathic Pain Treatment: A Review Based on Receptor Ligands","volume":"21","author":"Panczyk","year":"2015","journal-title":"Curr. Pharm. Des."},{"issue":"6","key":"10.1016\/j.bioorg.2020.104557_b0290","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1523\/JNEUROSCI.2468-16.2016","article-title":"5-HT2C Receptor Knockdown in the Amygdala Inhibits Neuropathic-Pain-Related Plasticity and Behaviors","volume":"37","author":"Ji","year":"2017","journal-title":"J. Neurosci."},{"issue":"19","key":"10.1016\/j.bioorg.2020.104557_b0295","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00213-017-4686-6","article-title":"5-HT modulation of pain perception in humans","volume":"234","author":"Martin","year":"2017","journal-title":"Psychopharmacology (Berl.)"},{"issue":"11","key":"10.1016\/j.bioorg.2020.104557_b0300","doi-asserted-by":"crossref","DOI":"10.1002\/syn.22059","article-title":"Cyanobacterial extract with serotonin receptor subtype 7 (5-HT7R) affinity modulates depression and anxiety-like behavior in mice","volume":"72","author":"Lax","year":"2018","journal-title":"Synapse"},{"issue":"5","key":"10.1016\/j.bioorg.2020.104557_b0305","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2170\/jjphysiol.48.333","article-title":"Plasma levels of 5-HT and 5-HIAA increased after intestinal ischemia\/reperfusion in rats","volume":"48","author":"Teramoto","year":"1998","journal-title":"The Japanese journal of physiology"},{"issue":"4","key":"10.1016\/j.bioorg.2020.104557_b0310","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3390\/ph12040149","article-title":"Lurasidone Sub-Chronically Activates Serotonergic Transmission via Desensitization of 5-HT1A and 5-HT7 Receptors in Dorsal Raphe Nucleus","volume":"12","author":"Okada","year":"2019","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2020.104557_b0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172964","article-title":"Antihyperalgesic effects of intrathecal perospirone in a rat model of neuropathic pain","volume":"195","author":"Haranishi","year":"2020","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"6","key":"10.1016\/j.bioorg.2020.104557_b0320","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0960-894X(98)00074-2","article-title":"1-[\u03c9-(4-Arylpiperazin-1-yl)alkyl]-3-diphenylmethylene-2,5-pyrrolidinediones as 5-HT1A receptor ligands: Study of the steric requirements of the terminal amide fragment on 5-HT1A affinity\/selectivity","volume":"8","author":"L\u00f3pez-Rodr\u00edguez","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"7","key":"10.1016\/j.bioorg.2020.104557_b0325","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ejmech.2006.03.001","article-title":"Synthesis, anticonvulsant activity and 5-HT1A, 5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-alkyl] derivatives of 2-azaspiro[4.4]nonane and [4.5]decane-1,3-dione","volume":"41","author":"Obniska","year":"2006","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0330","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejmech.2013.02.033","article-title":"Synthesis and biological evaluation of novel pyrrolidine-2,5-dione derivatives as potential antidepressant agents. Part 1","volume":"63","author":"Wrobel","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0335","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111736","article-title":"Synthesis and biological evaluation of new multi-target 3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives with potential antidepressant effect","volume":"183","author":"Wrobel","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0340","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ejmech.2017.12.099","article-title":"Synthesis and biological evaluation of a series of multi-target N-substituted cyclic imide derivatives with potential antipsychotic effect","volume":"145","author":"Xu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0345","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2020.103662","article-title":"Synthesis of new 4-butyl-arylpiperazine-3-(1H-indol-3-yl)pyrrolidine-2,5-dione derivatives and evaluation for their 5-HT(1A) and D(2) receptor affinity and serotonin transporter inhibition","volume":"97","author":"Wr\u00f3bel","year":"2020","journal-title":"Bioorg. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104557_b0350","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharep.2014.08.002","article-title":"Antinociceptive properties of N-Mannich bases derived from 3-substituted pyrrolidine-2,5-dione in the formalin model of persistent pain in mice","volume":"67","author":"Obniska","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.bioorg.2020.104557_b0355","doi-asserted-by":"crossref","unstructured":"I. Bata, Z. Tomoskozi, P. Buzder-Lantos, A. Vasas, G. Szeleczky, S. Batori, V. Barta-Bodor, L. Balazs, G.G. Ferenczy, I. Discovery of a novel series of CXCR3 antagonists. Multiparametric optimization of N,N-disubstituted benzylamines, Bioorg. Med. Chem. Lett. 26(22) (2016) 5418-5428.","DOI":"10.1016\/j.bmcl.2016.10.035"},{"key":"10.1016\/j.bioorg.2020.104557_b0360","doi-asserted-by":"crossref","unstructured":"I. Bata, Z. Tomoskozi, P. Buzder-Lantos, A. Vasas, G. Szeleczky, L. Balazs, V. Barta-Bodor, G.G. Ferenczy, II. Discovery of a novel series of CXCR3 antagonists with a beta amino acid core, Bioorg. Med. Chem. Lett. 26(22) (2016) 5429-5437.","DOI":"10.1016\/j.bmcl.2016.10.038"},{"issue":"23","key":"10.1016\/j.bioorg.2020.104557_b0365","doi-asserted-by":"crossref","first-page":"9617","DOI":"10.1021\/acs.jmedchem.7b00974","article-title":"Discovery of a Novel and Selective Indoleamine 2,3-Dioxygenase (IDO-1) Inhibitor 3-(5-Fluoro-1H-indo1-3-yl)pyrrolidine-2,5-dione (EOS200271\/PF-06840003) and Its Characterization as a Potential Clinical Candidate","volume":"60","author":"Crosignani","year":"2017","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.bioorg.2020.104557_b0370","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/ardp.201500096","article-title":"Discovery of benzylidene derivatives as potent Syk inhibitors: synthesis, SAR analysis, and biological evaluation","volume":"348","author":"Zhang","year":"2015","journal-title":"Arch. Pharm. (Weinheim)"},{"key":"10.1016\/j.bioorg.2020.104557_b0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111893","article-title":"Pyrazolone structural motif in medicinal chemistry: Retrospect and prospect","volume":"186","author":"Zhao","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0380","doi-asserted-by":"crossref","first-page":"111863","DOI":"10.1016\/j.ejmech.2019.111863","article-title":"Design, synthesis, in-vitro, in-vivo and in-silico studies of pyrrolidine-2,5-dione derivatives as multitarget anti-inflammatory agents","volume":"186","author":"Jan","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104557_b0385","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bmc.2013.11.018","article-title":"Discovery of novel antitumor dibenzocyclooctatetraene derivatives and related biphenyls as potent inhibitors of NF-kappa B signaling pathway","volume":"22","author":"Yu","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104557_b0390","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1007\/s00044-015-1380-2","article-title":"Synthesis of acridine cyclic imide hybrid molecules and their evaluation for anticancer activity","volume":"24","author":"Kumar","year":"2015","journal-title":"Med. Chem. Res."},{"issue":"3","key":"10.1016\/j.bioorg.2020.104557_b0395","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.bmcl.2016.12.031","article-title":"Solvent free, catalyst free, microwave or grinding assisted synthesis of bis-cyclic imide derivatives and their evaluation for anticancer activity","volume":"27","author":"Kumar","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"10","key":"10.1016\/j.bioorg.2020.104557_b0400","doi-asserted-by":"crossref","first-page":"5398","DOI":"10.1021\/acs.jmedchem.0c00245","article-title":"Discovery of potent, selective, and orally bioavailable inhibitors of USP7 with in vivo antitumor activity","volume":"63","author":"Leger","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0405","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.ejmech.2019.06.094","article-title":"Synthesis and biological evaluation of novel benzylidene-succinimide derivatives as noncytotoxic antiangiogenic inhibitors with anticolorectal cancer activity in vivo","volume":"179","author":"Luo","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.bioorg.2020.104557_b0410","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/ph13010016","article-title":"Design, Synthesis and Biochemical Evaluation of Novel Ethanoanthracenes and Related Compounds to Target Burkitt's Lymphoma","volume":"13","author":"Byrne","year":"2020","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2020.104557_b0415","doi-asserted-by":"crossref","unstructured":"K. Tilekar, N. Upadhyay, S.R. C, F.-J. Meyer-Almes, F. Loiodice, N.Y. Anisimova, T.S. Spirina, D.V. Sokolova, G.B. Smirnova, V.S. Pokrovsky, J.-Y. Choe, V.S. Pokrovsky, A. Lavecchia, Synthesis and biological evaluation of pyrazoline and pyrrolidine-2,5-dione hybrids as potential antitumor agents, Chemmedchem (2020) DOI: 10.1002\/cmdc.202000458.","DOI":"10.1002\/cmdc.202000458"},{"key":"10.1016\/j.bioorg.2020.104557_b0420","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ejmech.2013.09.041","article-title":"Design, chemical synthesis of 3-(9H-fluoren-9-yl)pyrrolidine-2,5-dione derivatives and biological activity against enoyl-ACP reductase (InhA) and Mycobacterium tuberculosis","volume":"70","author":"Matviiuk","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0425","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejmech.2013.10.069","article-title":"Synthesis of 3-heteryl substituted pyrrolidine-2,5-diones via catalytic Michael reaction and evaluation of their inhibitory activity against InhA and Mycobacterium tuberculosis","volume":"71","author":"Matviiuk","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0430","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111935","article-title":"Synthesis and anti-Mycobacterium tuberculosis activity of imide-beta-carboline and carbomethoxy-beta-carboline derivatives","volume":"187","author":"Lopes-Ortiz","year":"2020","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2020.104557_b0435","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3390\/molecules21030292","article-title":"Modified polyacrylic acid-zinc composites: synthesis, characterization and biological activity","volume":"21","author":"Shaik","year":"2016","journal-title":"Molecules"},{"issue":"7","key":"10.1016\/j.bioorg.2020.104557_b0440","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1021\/jm061484y","article-title":"N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop f isoindo l-2-(1H)-yl)carboxamides: Identification of novel orthopoxvirus egress inhibitors","volume":"50","author":"Bailey","year":"2007","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2020.104557_b0445","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/ardp.201500407","article-title":"New potent SARS-CoV 3C-like protease inhibitors derived from thieno 2,3-d pyrimidine derivatives","volume":"349","author":"Abd El-All","year":"2016","journal-title":"Arch. Pharm. (Weinheim)"},{"issue":"7","key":"10.1016\/j.bioorg.2020.104557_b0450","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.bbagen.2012.03.018","article-title":"Evaluation of in vitro and in vivo anti-melanogenic activity of a newly synthesized strong tyrosinase inhibitor (E)-3-(2,4-dihydroxybenzylidene)pyrrolidine-2,5-dione (3-DBP)","volume":"1820","author":"Chung","year":"2012","journal-title":"BBA-Gen. Subjects."},{"key":"10.1016\/j.bioorg.2020.104557_b0455","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.bioorg.2016.12.001","article-title":"Synthesis, characterization, anticancer, antimicrobial and carbonic anhydrase inhibition profiles of novel (3aR,4S,7R,7aS)-2-(4-((E)-3-(3-aryl)acryloyl) phenyl)-3a,4,7,7a-tetrahydro-1H-4,7-methanoisoindole-1,3(2H)-dione derivatives","volume":"70","author":"Kocyigit","year":"2017","journal-title":"Bioorg. Chem."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104557_b0460","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00044-017-1865-2","article-title":"Synthesis of 3-chloro-1-substituted aryl pyrrolidine-2,5-dione derivatives: discovery of potent human carbonic anhydrase inhibitors","volume":"26","author":"Oktay","year":"2017","journal-title":"Med. Chem. Res."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104557_b0465","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1021\/jm00154a016","article-title":"Synthesis and biochemical evaluation of analogues of aminoglutethimide based on phenylpyrrolidine-2,5-dione","volume":"29","author":"Daly","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2020.104557_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103128","article-title":"Synthesis, in-vitro alpha-glucosidase inhibition, antioxidant, in-vivo antidiabetic and molecular docking studies of pyrrolidine-2,5-dione and thiazolidine-2,4-dione derivatives","volume":"91","author":"Hussain","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.bioorg.2020.104557_b0475","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bmcl.2005.10.065","article-title":"In silico design and synthesis of piperazine-1-pyrrolidine-2,5-dione scaffold-based novel malic enzyme inhibitors","volume":"16","author":"Zhang","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2020.104557_b0480","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ejmech.2018.04.020","article-title":"Identification of novel beta-lactams and pyrrolidinone derivatives as selective Histamine-3 receptor (H3R) modulators as possible anti-obesity agents","volume":"152","author":"Ghoshal","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.bioorg.2020.104557_b0485","doi-asserted-by":"crossref","first-page":"11163","DOI":"10.1021\/acsomega.8b00959","article-title":"Chemical ligand space of cereblon","volume":"3","author":"Boichenko","year":"2018","journal-title":"ACS Omega"},{"issue":"4","key":"10.1016\/j.bioorg.2020.104557_b0490","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/med.21474","article-title":"Strategies to diversify natural products for drug discovery","volume":"38","author":"Li","year":"2018","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bioorg.2020.104557_b0495","doi-asserted-by":"crossref","unstructured":"F. Gao, J. Xiao, G. Huang, Current scenario of tetrazole hybrids for antibacterial activity, Eur. J. Med. Chem. 184 (2019) 111744-111744.","DOI":"10.1016\/j.ejmech.2019.111744"},{"key":"10.1016\/j.bioorg.2020.104557_b0500","doi-asserted-by":"crossref","unstructured":"H. Liu, S. Long, K.P. Rakesh, G.-F. Zha, Structure-activity relationships (SAR) of triazine derivatives: Promising antimicrobial agents, Eur. J. Med. Chem. 185 (2020) 111804-111804.","DOI":"10.1016\/j.ejmech.2019.111804"},{"issue":"9","key":"10.1016\/j.bioorg.2020.104557_b0505","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201900045","article-title":"Quinolone derivatives: Potential anti-HIV agent-development and application","volume":"352","author":"Wang","year":"2019","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.bioorg.2020.104557_b0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103021","article-title":"Medicinal chemistry of indole derivatives: Current to future therapeutic prospectives","volume":"89","author":"Kumari","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2020.104557_b0515","doi-asserted-by":"crossref","first-page":"536","DOI":"10.2174\/1386207317666140122101631","article-title":"\u201cOld friends in new guise\u201d: exploiting privileged structures for scaffold re-evolution\/refining","volume":"17","author":"Song","year":"2014","journal-title":"Comb. Chem. High Throughput Screen."},{"issue":"40","key":"10.1016\/j.bioorg.2020.104557_b0520","doi-asserted-by":"crossref","first-page":"7141","DOI":"10.2174\/13816128113199990505","article-title":"Heterocycle-thioacetic acid motif: a privileged molecular scaffold with potent, broad-ranging pharmacological activities","volume":"19","author":"Song","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"8","key":"10.1016\/j.bioorg.2020.104557_b0525","first-page":"1528","article-title":"Privileged scaffolds or promiscuous binders: a glance of pyrrolo[2,1-f][1,2,4]triazines and related bridgehead nitrogen heterocycles in medicinal chemistry","volume":"19","author":"Song","year":"2013","journal-title":"Curr. Pharm. Des."},{"issue":"5","key":"10.1016\/j.bioorg.2020.104557_b0530","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2217\/epi-2015-0002","article-title":"TCPs: privileged scaffolds for identifying potent LSD1 inhibitors for cancer therapy","volume":"8","author":"Zheng","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.bioorg.2020.104557_b0535","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ejmech.2019.04.032","article-title":"Perspectives of medicinally privileged chalcone based metal coordination compounds for biomedical applications","volume":"174","author":"Mahapatra","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.bioorg.2020.104557_b0540","doi-asserted-by":"crossref","first-page":"265","DOI":"10.4155\/fmc-2018-0489","article-title":"Designing influenza polymerase acidic endonuclease inhibitors via 'privileged scaffold' re-evolution\/refining strategy","volume":"11","author":"Ju","year":"2019","journal-title":"Future Med. Chem."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820318551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206820318551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T08:16:00Z","timestamp":1758615360000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206820318551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":108,"alternative-id":["S0045206820318551"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104557","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research progress in biological activities of succinimide derivatives","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2020.104557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"104557"}}